Drugs / GarlicinTM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00029250 | Nov 2001 → May 2003 | HIV infectious disease, hyperglycemia, hyperlipoproteinemia, hypertriglyceridemia | National Center for Complementary and Integrative Health (NCCIH) | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GarlicinTM | “We will utilize GarlicinTM, an allicin-standardized dried garlic supplement in two escalating doses in HIV-infected subjects who are receiving HAART.” NCT00029250 ↗ |